FDA Approves First Alzheimer’s Drug in Years | Newark News

FDA just approved Leqembi, the first drug in years to target Alzheimer’s by clearing amyloid plaques—offering hope for early-stage patients but with caveats: regular IV infusions, brain swelling risks, and modest slowing of decline. Long-term data still needed, but this is a major step forward in a long-stalled fight against the disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4179caa034fcd1dd